The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s low-density lipoprotein test market report forecasts the low-density lipoprotein test market size to grow to $9.47 Billion by 2027, with a CAGR (compound annual growth rate) of almost 4%.

Learn More On The Low-Density Lipoprotein Test Market Report 2023 – https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

Low-Density Lipoprotein Test Market Size Forecast
The global low-density lipoprotein test market is expected to grow from $7.80 billion in 2022 to $8.13 billion in 2023 at a compound annual growth rate (CAGR) of 4.14%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global low-density lipoprotein test market size is expected to reach $9.47 billion in 2027 at a CAGR of 3.91%.

North America held the largest low-density lipoprotein test market share.

Key Low-Density Lipoprotein Test Market Driver ­– Rise In The Prevalence Of Cardiovascular Diseases
According to the Centres for Disease Control and Prevention (CDC), a US-based national public health body, heart disease will be the leading cause of death in the United States in October 2022 for both genders and members of the majority of racial and ethnic groups. In the United States in 2020, heart disease claimed about 697,000 lives, accounting for one out of every five deaths. Coronary heart disease, the most common type of heart disease, killed 382,820 persons in 2020. As a result, the rising frequency of cardiovascular disorders is propelling the low-density lipoprotein test market forward.

Request for A Sample Of The Global Low-Density Lipoprotein Test Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9395&type=smp

Key Low-Density Lipoprotein Test Market Trend – Product Innovations
To maintain their market position, major businesses in the low-density lipoprotein test market are offering innovative products. For example, Novartis AG, a Swiss multinational pharmaceutical business, will launch Leqvio (Inclisiran) in December 2021, a first-in-class siRNA (small interfering RNA medication) to decrease low-density lipoprotein cholesterol. This drug reduces low-density lipoprotein cholesterol effectively and sustainably. Leqvio is the first and only FDA-approved small interfering RNA (siRNA) drug for decreasing LDL-C (bad cholesterol), requiring only two maintenance doses per year. Leqvio provides an effective and long-lasting LDL-C reduction of up to 52% in contrast to placebo in some individuals with atherosclerotic cardiovascular disease (ASCVD) taking maximally tolerated statin treatment. Leqvio is a revolutionary way for lowering LDL-C that also opens up new possibilities for how healthcare systems can impact cardiovascular disease.

Low-Density Lipoprotein Test Market Segment
1) By Product Type: LDL-C, LDL-P, LDL-B, Other Products
2) By Component: Kits, Reagents, Devices, Other Components
3) By Disease Type: Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Other Disease Types
4) By Distribution Channel: Direct Tenders, Retail
5) By End User: Hospitals, Clinics, Ambulatory Care, Research Laboratory, Other End Users

Low-Density Lipoprotein Test Market Major Players and Strategies
Major players in the low-density lipoprotein test market are Abbott Laboratories, Qiagen N.V., Randox Laboratories Ltd., Eurofins Scientific SE, Danaher Corporation, Bio-Rad Laboratories Inc., OPKO Health Inc., Lincoln Diagnostics LLC, DiaSorin S.p.A., Boster Biological Technology Ltd., Rockland Immunochemicals Inc., QIAGEN N.V., Sekisui Diagnostics LLC, DiaSys Diagnostic Systems GmbH, Eurolyser Diagnostica GmbH, Diazyme Laboratories Inc., Cell Biolabs Inc, Home Access Health Corporation, and Thermo Fisher Scientific Inc.

Novartis AG, a Swiss pharmaceutical business, paid $9.7 billion for The Medicines Company in January 2020. Novartis would acquire the investigational cholesterol-lowering medication inclisiran, which could be the first of its type. This acquisition would provide Novartis with a once-in-a-lifetime opportunity to write a new chapter in the use of a vaccine-like method to treat the world’s leading cause of death and disability. The Medicines business is a biotechnology business established in the United States that develops medications to lower LDL (low-density lipoprotein) cholesterol.

The Low-Density Lipoprotein Test Global Market Report 2023 covers regional data on low-density lipoprotein test market size, low-density lipoprotein test market trends and drivers, opportunities, strategies, and low-density lipoprotein test market competitor analysis. The countries covered in the low-density lipoprotein test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The low-density lipoprotein (LDL) test is a type of blood test used by doctors to determine the LDL cholesterol levels in a patient’s bloodstream. LDL testing can be performed separately or as part of a lipid panel test. Low-density lipoprotein is a type of cholesterol buildup in the arteries that can lead to heart attacks and strokes.

View More Reports Related To The Low-Density Lipoprotein Test Market –
Low-Density Polyethylene Global Market Report 2023
Low Intensity Sweeteners Global Market Report 2023
Low Power Geolocation Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: